Continue to site >
Trending ETFs

Name

As of 10/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$36.34

$1.78 B

1.12%

$0.41

0.71%

Vitals

YTD Return

21.7%

1 yr return

43.3%

3 Yr Avg Return

6.9%

5 Yr Avg Return

14.3%

Net Assets

$1.78 B

Holdings in Top 10

65.5%

52 WEEK LOW AND HIGH

$36.1
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 0.71%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 72.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

$500


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 10/04/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$36.34

$1.78 B

1.12%

$0.41

0.71%

FBTIX - Profile

Distributions

  • YTD Total Return 21.7%
  • 3 Yr Annualized Total Return 6.9%
  • 5 Yr Annualized Total Return 14.3%
  • Capital Gain Distribution Frequency Semi-Annually
  • Net Income Ratio 0.47%
DIVIDENDS
  • Dividend Yield 1.1%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Fidelity Advisor Biotechnology Fund
  • Fund Family Name
    Fidelity Investments
  • Inception Date
    Jan 12, 2001
  • Shares Outstanding
    N/A
  • Share Class
    I
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Eirene Kontopoulos

Fund Description

Normally investing primarily in common stocks. Normally investing at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. Investing in domestic and foreign issuers. Using fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
Read More

FBTIX - Performance

Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
YTD 21.7% -25.6% 24.8% 1.89%
1 Yr 43.3% -7.1% 46.1% 1.26%
3 Yr 6.9%* -30.1% 13.7% 23.03%
5 Yr 14.3%* -2.6% 16.2% 11.64%
10 Yr 8.9%* -0.7% 13.6% 47.75%

* Annualized

Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
2023 9.4% -12.6% 19.0% 11.95%
2022 -7.7% -53.9% 3.2% 20.39%
2021 -18.7% -39.6% 24.2% 82.89%
2020 22.8% -13.6% 178.2% 18.79%
2019 18.5% 3.8% 63.8% 71.43%

Total Return Ranking - Trailing

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
YTD 21.7% -25.6% 24.8% 1.89%
1 Yr 43.3% -7.1% 46.1% 1.26%
3 Yr 6.9%* -30.1% 13.7% 23.03%
5 Yr 14.3%* -2.6% 16.2% 11.64%
10 Yr 8.9%* -0.7% 13.6% 47.75%

* Annualized

Total Return Ranking - Calendar

Period FBTIX Return Category Return Low Category Return High Rank in Category (%)
2023 11.0% -12.6% 19.0% 13.21%
2022 -7.7% -53.9% 3.7% 33.55%
2021 -3.3% -33.9% 26.0% 81.58%
2020 32.5% -0.7% 180.6% 24.83%
2019 26.1% 4.6% 63.8% 48.12%

NAV & Total Return History


FBTIX - Holdings

Concentration Analysis

FBTIX Category Low Category High FBTIX % Rank
Net Assets 1.78 B 6.87 M 47.2 B 27.67%
Number of Holdings 100 26 414 37.74%
Net Assets in Top 10 1.19 B 2.12 M 22.1 B 23.27%
Weighting of Top 10 65.51% 18.4% 79.7% 6.29%

Top 10 Holdings

  1. ABBVIE INC 18.21%
  2. AMGEN INC 9.43%
  3. Fidelity Securities Lending Cash Central Fund 9.12%
  4. REGENERON PHARMACEUTICALS INC 7.01%
  5. VERTEX PHARMACEUTICALS INC 4.72%
  6. ALNYLAM PHARMACEUTICALS INC 4.53%
  7. ARGENX SE SPONSORED ADR 3.76%
  8. ASCENDIS PHARMA AS SPON ADR 3.50%
  9. VAXCYTE INC 2.61%
  10. CYTOKINETICS INC 2.60%

Asset Allocation

Weighting Return Low Return High FBTIX % Rank
Stocks
97.12% 87.34% 106.13% 71.70%
Cash
10.29% 0.00% 32.72% 8.18%
Preferred Stocks
1.80% 0.00% 7.86% 13.84%
Bonds
0.05% 0.00% 12.39% 20.75%
Other
0.00% -22.99% 23.61% 67.92%
Convertible Bonds
0.00% 0.00% 0.37% 51.95%

Stock Sector Breakdown

Weighting Return Low Return High FBTIX % Rank
Healthcare
100.00% 59.26% 100.00% 27.27%
Utilities
0.00% 0.00% 0.00% 48.70%
Technology
0.00% 0.00% 22.69% 51.95%
Real Estate
0.00% 0.00% 5.89% 51.30%
Industrials
0.00% 0.00% 7.02% 51.95%
Financial Services
0.00% 0.00% 1.60% 64.94%
Energy
0.00% 0.00% 0.00% 48.70%
Communication Services
0.00% 0.00% 9.11% 51.95%
Consumer Defense
0.00% 0.00% 25.73% 55.84%
Consumer Cyclical
0.00% 0.00% 1.92% 51.30%
Basic Materials
0.00% 0.00% 7.16% 66.23%

Stock Geographic Breakdown

Weighting Return Low Return High FBTIX % Rank
US
96.03% 66.06% 104.41% 40.25%
Non US
1.09% 0.00% 28.87% 57.86%

Bond Sector Breakdown

Weighting Return Low Return High FBTIX % Rank
Cash & Equivalents
10.29% 0.00% 100.00% 9.43%
Derivative
0.00% 0.00% 23.61% 60.38%
Securitized
0.00% 0.00% 0.00% 47.83%
Corporate
0.00% 0.00% 81.57% 56.52%
Municipal
0.00% 0.00% 0.00% 47.83%
Government
0.00% 0.00% 29.44% 48.55%

Bond Geographic Breakdown

Weighting Return Low Return High FBTIX % Rank
US
0.05% 0.00% 11.75% 20.75%
Non US
0.00% 0.00% 3.33% 49.06%

FBTIX - Expenses

Operational Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.71% 0.08% 4.48% 75.47%
Management Fee 0.69% 0.03% 1.25% 54.09%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% 92.68%

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

FBTIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 72.00% 0.00% 238.00% 85.93%

FBTIX - Distributions

Dividend Yield Analysis

FBTIX Category Low Category High FBTIX % Rank
Dividend Yield 1.12% 0.00% 6.24% 23.90%

Dividend Distribution Analysis

FBTIX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual Annual Annual

Net Income Ratio Analysis

FBTIX Category Low Category High FBTIX % Rank
Net Income Ratio 0.47% -2.54% 1.85% 15.79%

Capital Gain Distribution Analysis

FBTIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Semi-Annually Annually Semi-Annually Annually

Distributions History

View More +

FBTIX - Fund Manager Analysis

Managers

Eirene Kontopoulos


Start Date

Tenure

Tenure Rank

Jul 15, 2018

3.88

3.9%

Eirene Kontopoulos joined Fidelity Investments in 2007, she has worked as a research analyst and portfolio manager.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25